ALLHAT was the largest antihypertensive treatment trial and the
second largest lipid-lowering trial ever conducted. It also was a landmark cost-effectiveness
study. The large size and diversity of participants, varied practice settings, and
primary and secondary outcomes measured in ALLHAT makes the ALLHAT data set highly
useful for epidemiologic investigations.